The involvement of the RAAS in the development of LVH in hypertension is evidenced by the efficacy of the angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in preventing/regressing hypertensive LVH [27]. The gene discussed is ACE; the disease is hypertensive disorder.